A few months back I wrote this article entitled ”Reality Stems Stem Cell Breakthrough.” In it, I urged people expecting miracle breakthroughs in stem cell research to keep a lid on their expectations for a variety of reasons which are outlined in the article.
Yesterday, however, Technology Review ran an insightful article entitled ”Selling Stem Cells.” What is interesting about the article is that it doesn’t focus on some great “potential” breakthrough, rather it explains how some seasoned stem cell researchers are now developing the tools needed to produce stem cells on an industrial scale.
From my perspective this represents a significant step because it suggests that the field of stem cell medicine is slowly maturing. Now, I would still advise readers not to expect miracle stem cell therapies to arrive anytime soon, but the timeframe 2015 to 2020 now appears reasonable.
Interested in other glimpses into the future of health care? Check out these past posts:
A Glimpse into the Future of Regenerative Medicine
The Future is About to Get Personal
The Coming Health Care Revolution
Visualize the Future of Health Care
Be Still My Virtual Heart
The Future of Health Care: Part 2
The Future of Health Care
Why the Health Care Sector Should Give a Rat’s Ass
Mayo Clinic Has Got Some Game
Hospitals Need to Get Plastered
The Future of Organ Sales
Jack Uldrich is a writer, futurist, public speaker and host of jumpthecurve.net. He is the author of seven books, including Jump the Curve and The Next Big Thing is Really Small: How Nanotechnology Will Change the Future of Your Business. He is also a frequent speaker on future technology and future trends, nanotechnology, innovation, change management and executive leadership to a variety of businesses, industries and non-profit organizations and trade associations.
